A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia

Leukemia. 2018 Mar;32(3):839-843. doi: 10.1038/leu.2017.319. Epub 2017 Nov 3.

H Sakai^{1

2}, N Hosono¹, H Nakazawa², B Przychodzen¹, C Polprasert¹, H E Carraway¹, M A Sekeres^{1

3}, T Radivoyevitch¹, K Yoshida^{4

5}, M Sanada^{4

5

6}, T Yoshizato^{4

5}, K Kataoka^{4

5}, M M Nakagawa⁴, H Ueno⁴, Y Nannya⁴, A Kon^{4

5}, Y Shiozawa^{4

5}, J Takeda⁴, Y Shiraishi⁷, K Chiba⁷, S Miyano⁷, J Singh⁸, R A Padgett⁸, S Ogawa^{4

5}, J P Maciejewski¹, H Makishima^{1

2

4}

¹ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
² Division of Hematology, Department of Internal Medicine, Shinshu University, Matsumoto, Japan.
³ Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
⁴ Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.
⁵ Cancer Genomics Project, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
⁶ Clinical Research Center, Nagoya Medical Center, Nagoya, Japan.
⁷ Laboratory of Sequence Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
⁸ Department of Molecular Genetics, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

No abstract available

Publication types